RYMLISK
DEAD

Serial Number

97175656

Owner

Eagle Pharmaceuticals, Inc.

Attorney

Jacqueline M. Lesser

Filing Date

Dec 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RYMLISK Trademark

Serial Number: 97175656

RYMLISK is a trademark filed by Eagle Pharmaceuticals, Inc. on December 16, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Eagle Pharmaceuticals, Inc. (30 trademarks)

50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Entity Type: 03

Trademark Details

Filing Date

December 16, 2021

Registration Date

Not Registered

Published for Opposition

September 13, 2022

Goods & Services

Pharmaceutical products, namely, pharmaceutical preparations for supraventricular tachycardia, atrial fibrillation, and atrial flutter

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 27, 2026 ASCK
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 12, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 12, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 8, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 9, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2021 NWOS
NEW APPLICATION ENTERED
Dec 20, 2021 NWAP